The U.S. stock market today (Monday) opened lower as investors cautiously await this week's FOMC meeting. At the meeting, Fed officials will decide whether to raise interest rates for the first time since June 2006.
The Dow Jones Industrial Average, S& 500, and Nasdaq all opened firmly lower this morning. Just after noon, the three major benchmarks were down 0.44%, 0.48%, and 0.46%, respectively.
Here's what else investors need to know about the FOMC's impact on the stock market today...
The U.S. stock market today (Monday) opened lower as investors cautiously await this week's FOMC meeting. At the meeting, Fed officials will decide whether to raise interest rates for the first time since June 2006.
The Dow Jones Industrial Average, S& 500, and Nasdaq all opened firmly lower this morning. Just after noon, the three major benchmarks were down 0.44%, 0.48%, and 0.46%, respectively.
Here's what else investors need to know about the FOMC's impact on the stock market today...
Dow Jones today, August 13, 2014: U.S. stocks were in the red on Tuesday as concerns about the European markets affected investor sentiment. Geopolitical hot spots in Ukraine and in the Middle East have led to an increased emphasis on reducing exposure to risk.
Here’s what you should know to make your Wednesday profitable:
There were several hot stocks to watch today as all three indexes remained on the upswing hours into trading.
Retail sales dominated headlines Wednesday, with Barnes & Noble Inc. (NYSE: BKS), Target Corp. (NYSE: TGT), Abercrombie & Fitch Co. (NYSE: ANF), and TJX Co. (NYSE: TJX) all up in morning trading on better than expected earnings and/or guidance. After the close, investors hear from Baidu Inc. (Nasdaq ADR: BIDU) and J.C. Penney Co. Inc. (NYSE: JCP).
To continue reading, please click here...
When you're evaluating a biotech, or even a full-fledged pharmaceutical company, you'll want to look at its product pipeline, upcoming catalysts, and financial indicators.
But the most important asset it possesses, the heartbeat that drives everything else, is its intellectual property (patent) portfolio...
That's what will make it attractive for acquisition, merger, or licensing deals.
And it's what protects its products from marauding generic drug manufacturers, who will produce copycat therapies and sell them at cutthroat prices.
For a drug development company, that spells disaster.
Biotech stocks have delivered a healthy dose of returns to investors year to date. The iShares Nasdaq Biotech Index ETF (Nasdaq: IBB) is up a whopping 65% so far in 2014.
That follows a 60%-plus return last year, far outpacing the 30% gain of the broader market. Some 81 biotech companies saw share prices more than double in 2013.
To continue reading, please click here...
The market sell-off that started 2014 has turned around this week with the S&P 500 up 2.1% and the Dow Jones Industrial Average up 1.7%.
That has investors wondering if the market sell-off is over.
To continue reading, please click here...
For months, Wall Street insiders have passed this chart around amongst themselves and nervously discussed whether it foretells a major stock market sell-off.
The chart compares the path of the current Dow Jones Industrial Average over the past year and a half to the Dow's moves over the 1928-1929 period.
While the Dow is trading at a much higher level now than in the 1928-1929 period, the pattern is eerily similar to the path that led to the worst stock market crash in Wall Street history, right up to the recent stock market sell-off and recovery.
To continue reading, please click here...
Today's stock market news, Feb. 3: U.S. markets slumped on Friday and posted their worst month since May 2012.
The Dow Jones Industrial Average tumbled 4.88% in January. Last week, mixed earnings from retail and tech giants collided with renewed concerns about emerging markets and production declines in China.
With our eye on the Opening Bell, here are five stories to watch this morning.
To continue reading, please click here...
Best investments for the week ending Jan. 24, 2014: Stocks tumbled last week as investors fled global markets amid soft data out of China, and traders dumped crumbling emerging market currencies.
Disappointing Q4 earnings from a number of U.S. companies, including Johnson & Johnson (NYSE: JNJ) and Coach Inc. (NYSE: COH), also weighed on markets.
For the week, the Dow dropped 3.5% or 580 points, falling back below the 16,000 level to end at 15,879. The S&P shed 48 points, or 2.6%, slumping below 1,800 to end at 1,790. And the Nasdaq slipped 1.7%, or 69 points, to 4,128.
But Money Morning never slips - investors can always count on us to interpret the big market-moving events, sift through earnings reports, and share the best stocks to buy now.
Here's a recap from last week:
Stock Market Today, Dec. 30: In the second-to-last trading day of the year, stocks are fairly flat except for some double-digit movers in the consumer and biotech sectors, like Crocs Inc. (Nasdaq: CROX) stock.
The Dow Jones Industrial Average today clutched a small gain of 25 points while both the Standard & Poor's 500 and Nasdaq Composite Index ended in the red. They fell about 0.02% and 0.06%, respectively.
To continue reading, please click here...
Stock Market News Today, Dec. 12: U.S. stocks are weighed today after having started the day higher on upbeat retail sales data. They retreated on more concerns that the U.S. Federal Reserve will scale back its $85-billion-per-month bond-buying stimulus program.
The S&P 500 today fell 0.38%, or 6.72 points, at 1,775.50, and the Dow Jones Industrial Average lost 0.66%, or 104.03 points, at 15,739.50 points. The Nasdaq Composite Index fell 0.14%, or 5.41 points, at 3,998.40.
To continue reading, please click here...
When Thomas Edison perfected his light bulb, he didm't just want to change people's lives - he wanted to profit from one of the greatest advances in human history. More than a century later, Congress has banned the incandescent bulb, opening up a massive profit opportunity for the lighting technology that replaces it.
And here's a company that has a 25-year head start on capturing those profits...
Sysco definitely needed some kind of a jolt. Earnings this year were disappointing, with net profit down 12% from the previous year. Numbers like that put a drag on the stock, which was up only 8% in an otherwise booming market. But news that Sysco is buying U.S. Foods sent the stock soaring as much as 25%.
Here's why the deal has investors so thrilled...
Stock Market News Today, Nov. 25: Stocks are trading a bit higher this morning, with the Nasdaq topping 4,000 for the first time since 2000 and the Dow Jones Industrial Average and the S&P 500 primed for another record day.
The biggest market news today: Global leaders reached a deal with Iran regarding its nuclear program.
To continue reading, please click here...
Stock Market News Today, Nov. 21: U.S. stocks are continuing to rally today as the 30-year fixed mortgage rate dropped to 4.22% this week from 4.35% last week, and despite the fact that data showed manufacturing activity slowed this month.
The Philadelphia Fed's manufacturing index for October was 6.5 last month, down from 19.8 in October and below economists' expectations for 14.5. That data indicates slowing, but still positive general manufacturing activity.
To continue reading, please click here...
